Search

Your search keyword '"Plasmodium falciparum genetics"' showing total 8,758 results

Search Constraints

Start Over You searched for: Descriptor "Plasmodium falciparum genetics" Remove constraint Descriptor: "Plasmodium falciparum genetics"
8,758 results on '"Plasmodium falciparum genetics"'

Search Results

1. Evaluation of combination vaccines targeting transmission of Plasmodium falciparum and P. vivax.

2. High prevalence of asymptomatic and subpatent Plasmodium falciparum infections but no histidine-rich protein 2 gene deletion in Bouaké, Côte d'Ivoire.

3. Host Transcriptional Meta-signatures Reveal Diagnostic Biomarkers for Plasmodium falciparum Malaria.

4. Microheterogeneity of Transmission Shapes Submicroscopic Malaria Carriage in Coastal Tanzania.

5. Varied Prevalence of Antimalarial Drug Resistance Markers in Different Populations of Newly Arrived Refugees in Uganda.

6. Evaluation of the binding interactions between Plasmodium falciparum Kelch-13 mutant recombinant proteins with artemisinin.

7. Mutation of the Plasmodium falciparum Flavokinase Confers Resistance to Roseoflavin and 8-Aminoriboflavin.

8. A picomolar inhibitor of the Plasmodium falciparum IPP pathway.

9. Indigenous emergence and spread of kelch13 C469Y artemisinin-resistant Plasmodium falciparum in Uganda.

10. Malaria screening: what is the contribution of molecular biology?

11. Cryo-EM structure of 1-deoxy-D-xylulose 5-phosphate synthase DXPS from Plasmodium falciparum reveals a distinct N-terminal domain.

12. Plasmodium falciparum population dynamics in East Africa and genomic surveillance along the Kenya-Uganda border.

13. Diversity and selection analyses identify transmission-blocking antigens as the optimal vaccine candidates in Plasmodium falciparum.

15. Deciphering the Plasmodium falciparum perinuclear var gene expression site.

16. Plasmodium RNA triphosphatase validation as antimalarial target.

17. Repurposing DrugBank compounds as potential Plasmodium falciparum class 1a aminoacyl tRNA synthetase multi-stage pan-inhibitors with a specific focus on mitomycin.

18. Additional blood meals increase sporozoite infection in Anopheles mosquitoes but not Plasmodium falciparum genetic diversity.

19. Evidence on sulfadoxine-pyrimethamine resistance molecular markers from India: interpret with caution.

20. Transcriptomic analyses of differentially expressed human genes, micro RNAs and long-non-coding RNAs in severe, symptomatic and asymptomatic malaria infection.

21. A Plasmodium apicoplast-targeted unique exonuclease/FEN exhibits interspecies functional differences attributable to an insertion that alters DNA-binding.

22. Host cell CRISPR genomics and modelling reveal shared metabolic vulnerabilities in the intracellular development of Plasmodium falciparum and related hemoparasites.

23. Artemisinin-resistant malaria in Africa demands urgent action.

24. Evolution of pfhrp2 and pfhrp3 deletions in Equatorial Guinea between the pre- and post-RDT introduction.

25. An overview of artemisinin-resistant malaria and associated Pfk13 gene mutations in Central Africa.

26. A Plasmodium falciparum genetic cross reveals the contributions of pfcrt and plasmepsin II/III to piperaquine drug resistance.

27. Genomic surveillance of malaria parasites in an indigenous community in the Peruvian Amazon.

28. Asymptomatic malaria and predictors among migrant farmworkers East Shewa zone Oromia Ethiopia.

29. Molecular detection of sub-microscopic infections and Plasmodium falciparum histidine-rich protein-2 and 3 gene deletions in pre-elimination settings of South Africa.

30. Two decades of molecular surveillance in Senegal reveal rapid changes in known drug resistance mutations over time.

31. Flp/ FRT -mediated disruption of ptex150 and exp2 in Plasmodium falciparum sporozoites inhibits liver-stage development.

32. Antimalarial resistance risk in Mozambique detected by a novel quadruplex droplet digital PCR assay.

33. Transcriptional responses of brain endothelium to Plasmodium falciparum patient-derived isolates in vitro .

34. Still time to contain artemisinin resistance in Africa.

35. Diagnostic performance of an ultra-sensitive RDT and a conventional RDT in malaria mass testing, treatment and tracking interventions in southern Ghana.

36. Plasmodium falciparum gametocyte production correlates with genetic markers of parasite replication but is not influenced by experimental exposure to mosquito biting.

37. Plasmodium falciparum artemisinin resistance: something gained in translation.

38. Urgent action is needed to confront artemisinin partial resistance in African malaria parasites.

39. Comparison of prevalence estimates of pfhrp2 and pfhrp3 deletions in Plasmodium falciparum determined by conventional PCR and multiplex qPCR and implications for surveillance and monitoring.

40. Ancient Plasmodium genomes shed light on the history of human malaria.

41. Characterization of drug resistance genes in Indian Plasmodium falciparum and Plasmodium vivax field isolates.

42. Activation loop phosphorylation and cGMP saturation of PKG regulate egress of malaria parasites.

43. Strong isolation by distance and evidence of population microstructure reflect ongoing Plasmodium falciparum transmission in Zanzibar.

44. RNA polymerase III is involved in regulating Plasmodium falciparum virulence.

45. Solution-State Structure of a Long-Loop G-Quadruplex Formed Within Promoters of Plasmodium falciparum B var Genes.

46. LLIN Evaluation in Uganda Project (LLINEUP)-effects of a vector control trial on Plasmodium infection prevalence and genotypic markers of insecticide resistance in Anopheles vectors from 48 districts of Uganda.

47. Structure of an internal loop motif with three consecutive U•U mismatches from stem-loop 1 in the 3'-UTR of the SARS-CoV-2 genomic RNA.

48. Evaluation of Dihydroartemisinin-Piperaquine Efficacy and Molecular Markers in Uncomplicated Falciparum Patients: A Study across Binh Phuoc and Dak Nong, Vietnam.

49. Increased sensitivity of malaria parasites to common antimalaria drugs after the introduction of artemether-lumefantrine: Implication of policy change and implementation of more effective drugs in fight against malaria.

50. Detection of Duffy blood group genotypes and submicroscopic Plasmodium infections using molecular diagnostic assays in febrile malaria patients.

Catalog

Books, media, physical & digital resources